WeiDingMD

PubMed

• Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study.
  Herling, M., Dearden, C., Zaja, F., El-Sharkawi, D., Ding, W., Bellido, M., Khot, A., Tick, L., Jacobsen, E., Eyre, T., Roos-Weil, D., Kadia, T., Lucchini, E., Pflug, ...> ;Blood Advances. 2024 Feb 27
• 3 citations
  CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.
  R Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, Elizabeth L Siegler, James H Girsch, Olivia L Sirpilla, Carli M Stewart, Kun Yun, Ismail Can, Ekene J Ogbodo, ...> ;Blood. 2024 Jan 18
• AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.
  R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, Elizabeth L Siegler, Sutapa Sinha, Michael J Hansen, Carli M Stewart, Jennifer M Feigin, Claudia Manriquez Roman, Kenda...> ;Cancer Immunology Research. 2023 Sep 1
• Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
  Samuel R Kosydar, Sameer A Parikh, Scott C Lester, Kari G Rabe, Wei Ding, Jessica F Burlile, Saad S Kenderian, Yucai Wang, Eli Muchtar, Amber B Koehler, Susan M Schwag...> ;American Journal of Hematology. 2023 Nov 1
• 2 citations
  DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, m...
  Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqba...> ;American Journal of Hematology. 2023 May 1
• Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection.
  Kurt S Bantilan, Neil E Kay, Sameer A Parikh, Kari G Rabe, Timothy G Call, Jose F Leis, Wei Ding, Susan L Slager, Jacob D Soumerai, Lindsey E Roeker, Anthony Mato, And...> ;Leukemia & Lymphoma. 2023 Feb 1
• 4 citations
  Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
  Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Asher A Chanan-Khan, Saad S Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B Koehler,...> ;Blood Cancer Journal. 2022 Sep 1
• 6 citations
  Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia.
  Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Saad S Kenderian, Eli Muchtar, Yucai Wang, Amber B Koehler, Ricardo Parrondo, Susan M Schwager, Min ...> ;British Journal of Haematology. 2022 Oct 1
• 1 citations
  Serum B-Cell maturation antigen is an independent prognostic marker in previously untreated chronic lymphocytic leukemia.
  Camilia M Soof, Tanya M Spektor, Sameer A Parikh, Susan L Slager, Kari G Rabe, Timothy G Call, Saad S Kenderian, Wei Ding, Eli Muchtar, Matthew Ghermezi, Neil E Kay, J...> ;Experimental Hematology. 2022 Jul 1
• 1 citations
  Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.
  Paul J Kurtin, Rebecca L King, Ji Yuan, Andrew L Feldman, Karen L Rech, Ellen D McPhail, Sameer A Parikh, Wei Ding, Min Shi, Ravindran, A.> ;Human Pathology. 2022 Jul 1
• 69-Year-Old Man With Dysuria and Right Lower Abdominal Pain.
  Jana Wieland, Bryce Kalei Chang, Wei Ding> ;Mayo Clinic Proceedings. 2022 Jun 1
• 3 citations
  Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).
  Youssef Salama, Fang Zhao, Jennifer L Oliveira, Ji Yuan, Dragan Jevremovic, Ronald S Go, Wei Ding, Sameer A Parikh, Mithun V Shah, Paul J Hampel, Aref Al-Kali, William...> ;Blood Cancer Journal. 2022 Feb 22
• 8 citations
  Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
  Rebecca L King, Alia Gupta, Paul J Kurtin, Wei Ding, Timothy G Call, Kari G Rabe, Saad S Kenderian, Jose F Leis, Yucai Wang, Susan M Schwager, Susan L Slager, Neil E K...> ;Blood Cancer Journal. 2022 Jan 28
• 1 citations
  Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome.
  Hanyin Wang, Shulan Tian, Qing Zhao, Wendy M. Blumenschein, Jennifer H. Yearley, Charla R. Secreto, Sutapa Sinha, Timothy G. Call, Yucai Wang, Sameer A. Parikh, Saad J...> ;Hematological Oncology. 2021 Nov 22
• 13 citations
  Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
  Eli Muchtar, Amber B. Koehler, Michael J. Johnson, Kari G. Rabe, Wei D Ding, Timothy G. Call, Jose F. Leis, Saad S. Kenderian, Suzanne R. Hayman, Yucai Wang, Paul J. H...> ;American Journal of Hematology. 2021 Oct 26
• 6 citations
  Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index.
  Yucai Wang, Sara J. Achenbach, Kari G. Rabe, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber B. Koehler, Susan M. Sch...> ;Blood Cancer Journal. 2021 Aug 5
• 12 citations
  Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202.
  Amy S. Ruppert, Allison M Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander, Steven Coutre, Jennifer R. Brown, Sreenivasa Nattam, Richard A. Larson, Harry P. Erb...> ;Leukemia. 2021 Jul 17
• 16 citations
  The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
  Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Timothy G. Call, Wei Ding, Jose F. Leis, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Amber B. Koehler, Susan M. Schwager, ...> ;Blood. 2021 Jul 15
• 1 citations
  The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and Beyond.
  Wei Ding> ;Hematology/oncology Clinics of North America. 2021 May 28
• 14 citations
  Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
  Yucai Wang, Sutapa Sinha, Linda Wellik, Charla R. Secreto, Karen L. Rech, Timothy G. Call, Sameer A. Parikh, Saad S. Kenderian, Eli Muchtar, Suzanne R. Hayman, Amber B...> ;Blood Cancer Journal. 2021 May 10
• 35 citations
  Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.
  Jing Zhou Hou, Jing Christine Ye, Jeffrey J. Pu, Hongtao Liu, Wei Ding, Hong Zheng, Delong Liu> ;Journal of Hematology & Oncology. 2021 Apr 21
• 3 citations
  Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia.
  Shulan Tian, Henan Zhang, Pan Zhang, Michael T Kalmbach, Jeong Heon Lee, Tamas Ordog, Paul J. Hampel, Timothy G. Call, Thomas E. Witzig, Neil E. Kay, Eric W. Klee, Sus...> ;Scientific Reports. 2021 Apr 15
• 1 citations
  The prognostic significance of del6q23 in chronic lymphocytic leukemia.
  Hadiyah Y. Audil, Paul J. Hampel, Daniel L. Van Dyke, Sara J. Achenbach, Kari G. Rabe, Stephanie A. Smoley, Timothy G. Call, Wei Ding, Min Shi, Curtis A. Hanson, Yucai...> ;American Journal of Hematology. 2021 Mar 22
• 6 citations
  Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
  Paul J. Hampel, Sameer A. Parikh, Timothy G. Call, Mithun Vinod Shah, N. Nora Bennani, Aref Al-Kali, Kari G. Rabe, Yucai Wang, Eli Muchtar, Jose F. Leis, Saad S. Kende...> ;Blood Cancer Journal. 2021 Mar 2
• 1 citations
  Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance.
  Sutapa Sinha, Charla R. Secreto, Justin C. Boysen, Connie Lesnick, Zhiquan Wang, Wei Ding, Timothy G. Call, Saad J. Kenderian, Sameer A. Parikh, Steven L. Warner, Davi...> ;Blood Cancer Journal. 2021 Feb 18
• Join now to see all

Journal Articles

• Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Centre  
  Sameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology

Abstracts/Posters

• The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis
  Wei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (_ 70 Years...
  Wei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression
  Wei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (_ 70 Years...
  Wei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphoc...
  Wei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (C...
  Wei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Role for TNF-_ in Chronic Lymphocytic Leukemia Bone Marrow Hematopoietic Dysfunction
  Wei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalid...
  Wei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• The Future of Chronic Lymphocytic Leukemia (CLL) Therapy 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Future of Chronic Lymphocytic Leukemia (CLL) Therapy 
  60th American Society of Hematology Annual Meeting - 12/1/2018